SEARCH

SEARCH BY CITATION

References

  • 1
    Bradwejn J, Koszycki D, Meterissian G. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Can. J. Psychiatry 1990; 35: 8385.
  • 2
    Bradwejn J, Koszycki D, Couetoux du Tertre A, van Megen H, den Boer J, Westenberg H. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365, 260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch. Gen. Psychiatry 1994; 51: 486493.
  • 3
    Kaplan DS, Masand PS, Gupta S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann. Clin. Psychiatry 1996; 8: 8188.
  • 4
    Noyes R, Cook B, Garvey M, Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990; 31: 7579.
  • 5
    Yoshizawa M, Endo Y, Fukudo S et al. The relationship of panic disorder and irritable bowel syndrome. Jpn. J. Psychosom. Med. 2000; 40: 283289 (in Japanese).
  • 6
    Lydiard BR, Greenwald S, Weissman MM, Johnson J, Droeeman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: Findings from the NIMH Epidemiologic Catchment Area project. Am. J. Psychiatry 1994; 151: 6470.
  • 7
    Sugaya N, Kaiya H, Kumano H, Nomura S. The clinical characteristics of panic disorder patients with irritable bowel syndrome. Jpn. J. Psychosom. Med. 2005; 45: 915922.
  • 8
    Elam M, Thoren P, Svensson TH. Locus coeruleus neurons and sympathetic nerves: Activation by visceral afferents. Brain Res. 1986; 375: 117125.
  • 9
    Svensson TH. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: Putative implications for psychiatry to psychopharmacology. Psychopharmacology (Berl) 1987; 92: 17.
  • 10
    Bourin M, Baker GB, Bradwejn J. Neurobiology of panic disorder. J. Psychosom. Res. 1998; 44: 163180.
  • 11
    Redmond DE Jr, Huang YH. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci. 1979; 25: 21492162.
  • 12
    Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990; 99: 16881704.
  • 13
    Maunder RG. Panic disorder associated with gastrointestinal disease: Review and hypotheses. J. Psychosom. Res. 1998; 44: 91105.
  • 14
    Sugaya N, Nomura S, Shimada H. Relationship between cognitive factors and anxiety in individuals with irritable bowel syndrome. Int. J. Behav. Med. 2012; 19: 308315.
  • 15
    Stewart SH, Knize K, Pihl RO. Anxiety sensitivity and dependency in clinical and nonclinical panickers and controls. J. Anxiety Disord. 1992; 6: 119131.
  • 16
    Reiss S, McNally RJ. The expectancy model of fear. In: Reiss S , Bootzin R (eds). Theoretical Issues in Behavior Therapy. Academic Press, New York, 1985; 107121.
  • 17
    Hazlett-Stevens H, Craske MG, Mayer EA, Chang L, Naliboff BD. Prevalence of irritable bowel syndrome among university students: The roles of worry, neuroticism, anxiety sensitivity and visceral anxiety. J. Psychosom. Res. 2003; 55: 501505.
  • 18
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 1994.
  • 19
    Sheehan DV, Lecrubier Y, Harnett-Sheehan K et al. The Mini International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview. J. Clin. Psychiatry 1998; 59: 2233.
  • 20
    Drossman DA, Talley NJ, Whitehead WE, Corazziari E. Research diagnostic questions for functional gastrointestinal disorders: Rome II Modular Questionnaire: Investigations and respondent forms. In: Drossman DA , Corazziari E , Talley NJ , Thompson WG (eds). Rome II The Functional Gastrointestinal Disorders, 2nd edn. Degnon Associates, McLean, VA, 2000; 669714.
  • 21
    Shinozaki M, Kanazawa M, Sagami Y et al. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J. Gastroenterol. 2006; 41: 491494.
  • 22
    Peterson RA, Reiss S. Anxiety Sensitivity Index Manual, 2nd edn. International Diagnostic Systems, Worthington, OH, 1992.
  • 23
    Maruta T, Yamate T, Ito K, Sato M, Iimori M, Kato M. Reliability and validity of the Japanese version of the Anxiety Sensitivity Index. Compr. Psychiatry 2007; 48: 289292.
  • 24
    Suzuki S, Sakano Y. Development of a Cognitive Appraisal for Rating Scale (CARS) and its validation. Hum. Sci. Res. 1998; 7: 113124 (in Japanese).
  • 25
    Lazarus RS, Folkman S. Stress, Appraisal, and Coping. Springer Publishing Company, New York, 1984.
  • 26
    Saviotti FM, Grandi S, Savron G et al. Characterological traits of recovered patients with panic disorder and agoraphobia. J. Affect. Disord. 1991; 23: 113117.
  • 27
    Schmidt NB, Cook JH. Effects of anxiety sensitivity on anxiety and pain during a cold pressor challenge in patients with panic disorder. Behav. Res. Ther. 1999; 37: 313323.
  • 28
    Sykes MA, Blanchard EB, Lackner J, Keefer L, Krasner S. Psychopathology in irritable bowel syndrome: Support for a psychophysiological model. J. Behav. Med. 2003; 26: 361372.
  • 29
    Sugaya N, Izawa S, Kimura K et al. Adrenal hormone response and psychophysiological correlates under psychosocial stress in individuals with irritable bowel syndrome. Int. J. Psychophysiol. 2012; 84: 3944.
  • 30
    Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 13771390.